Some public health data targeted by Trump’s executive orders has been restored, but what’s changed and how will that affect health policy?
Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...
Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback